ArticleActa pharmaceutica Sinica. B2022

Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis.

Zhangxu He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.